Hair loss in cancer chemotherapeutic patients - PubMed (original) (raw)

. 2003 Mar-Apr;69(2):131-2.

Affiliations

• PMID: 17642856

Hair loss in cancer chemotherapeutic patients

V Chadha et al. Indian J Dermatol Venereol Leprol. 2003 Mar-Apr.

Abstract

The hair loss in 8 cancer patients aged between 18 and 60 years on chemotherapy was studied. All had diffuse moderate alopecia within 1 month of starting treatment. Of the 8, 3 had only telogen hairs and 3 had high dystrophic hair count. Both anagen and telogen effluvium are implicated.

PubMed Disclaimer

Similar articles

• 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
  Bleiker TO, Nicolaou N, Traulsen J, Hutchinson PE. Bleiker TO, et al. Br J Dermatol. 2005 Jul;153(1):103-12. doi: 10.1111/j.1365-2133.2005.06608.x. Br J Dermatol. 2005. PMID: 16029334 Clinical Trial.
• Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation.
  Yun SJ, Kim SJ. Yun SJ, et al. Dermatology. 2007;215(1):36-40. doi: 10.1159/000102031. Dermatology. 2007. PMID: 17587837
• Chronic telogen effluvium is due to a reduction in the variance of anagen duration.
  Gilmore S, Sinclair R. Gilmore S, et al. Australas J Dermatol. 2010 Aug;51(3):163-7. doi: 10.1111/j.1440-0960.2010.00654.x. Australas J Dermatol. 2010. PMID: 20695853
• Hair loss in systemic disease.
  Spencer LV, Callen JP. Spencer LV, et al. Dermatol Clin. 1987 Jul;5(3):565-70. Dermatol Clin. 1987. PMID: 3301113 Review.
• Diffuse hair loss: its triggers and management.
  Harrison S, Bergfeld W. Harrison S, et al. Cleve Clin J Med. 2009 Jun;76(6):361-7. doi: 10.3949/ccjm.76a.08080. Cleve Clin J Med. 2009. PMID: 19487557 Review.

Cited by

• The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial.
  You JS, Guo L, Huang M, Shi XL, Lin MD, Guo Z, Cao YL, Sun YZ, Xu Q, Qu WL, Liu HL, Chen JP. You JS, et al. Trials. 2019 Dec 12;20(1):719. doi: 10.1186/s13063-019-3893-3. Trials. 2019. PMID: 31831051 Free PMC article.
• Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors.
  Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB. Xue Z, et al. ACS Med Chem Lett. 2022 Sep 13;13(12):1864-1869. doi: 10.1021/acsmedchemlett.2c00308. eCollection 2022 Dec 8. ACS Med Chem Lett. 2022. PMID: 36518694 Free PMC article.
• Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study.
  Surendiran A, Balamurugan N, Gunaseelan K, Akhtar S, Reddy KS, Adithan C. Surendiran A, et al. Indian J Pharmacol. 2010 Feb;42(1):40-3. doi: 10.4103/0253-7613.62412. Indian J Pharmacol. 2010. PMID: 20606836 Free PMC article.